| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |